Omecamtiv Mecarbil Post-trial Access Study
NCT04464525
·
clinicaltrials.gov ↗
PHASE3
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Sponsor decision
Conditions
Chronic Heart Failure With Reduced Ejection Fraction
Interventions
DRUG:
Omecamtiv mecarbil
Sponsor
Cytokinetics